FDNA

FDNA develops AI technologies and SaaS platforms used by thousands of clinical, research and lab sites globally in the clinical genomics space. Using advanced deep learning, FDNA's next-generation phenotyping (NGP) technologies capture, structure, and analyze complex human physiological data to produce actionable genomic insights. Since its founding in 2011, FDNA has positioned itself at the forefront of AI, genomics, and precision medicine.